Healthy postmenopausal women not currently taking hormone replacement or hormone modulating
therapy take a 3-month course of estradiol/raloxifene/placebo to evaluate the effects of each
on vascular function, as indicated by PET coronary flow reserve studies and brachial artery
ultrasound, before and after use of the therapies. This is a randomized, placebo-controlled,
blinded study.
Phase:
Phase 4
Details
Lead Sponsor:
US Department of Veterans Affairs VA Office of Research and Development